James Schlottman, CEO and plan president of Centene’s Louisiana Healthcare Connections, is retiring, according to a May 14 LinkedIn post. Mr. Schlottman has spent over 15 years with the Medicaid plan. According to his profile, he previously worked at Humana,…
The Latest
From the Oval Office to Congress, fraud has become one of the loudest rallying cries of the federal government’s healthcare agenda this year. Minnesota was an early target of the Trump administration’s healthcare fraud crackdown, but the scrutiny has since…
CVS Health secured court approval to sell its long-term care pharmacy business, Omnicare, according to a May 13 news release and bankruptcy court filings. GenieRx, a partnership between a private investment firm and a healthcare investment and management firm, is buying the…
A federal jury in the Southern District of Florida convicted the founder and owner of HealthSplash for his role in a scheme that prosecutors said fraudulently billed Medicare and other federal healthcare programs more than $1 billion for medically unnecessary…
Dave Quinn will join Health Alliance Plan as vice president of growth May 18, according to a news release. In the newly formed role, Mr. Quinn will focus on the plan’s membership and administrative services only (ASO) business strategies, positioning…
Healthcare organizations are under increasing pressure to improve operational efficiency while supporting overextended clinical engineering teams. In this webinar, leaders will explore how agentic AI can help biomedical technicians streamline workflows, reduce administrative burden, and access faster troubleshooting and equipment…
Jun 23, 2026 12:00 PM - 1:00 PM CDT
Presented by:
Presenters:
- Murphy McGraw
- Lindsay Price
Two manufacturers filed a lawsuit against Blue Cross and Blue Shield of Texas over alleged prescription drug rebate fraud, according to an April complaint. Texas State Rep. James Frank, a Republican, is the CEO of Sharp Iron Group and Texas…
Payer–provider partnerships have long been a strategic priority in healthcare, but many organizations continue to struggle translating ambition into sustained, scalable results. Insights from industry leaders at Highmark, enGen, and ZS highlight a critical inflection point: success now depends less…
Cancer outcomes have improved but delays and fragmentation still define much of the care journey. Patients wait an average of 156 days between screening and diagnosis, and every four-week delay can increase mortality risk by 6 to 8 percent. For…
Presented by:
The problem usually isn’t the clinical strategy. It’s what happens after the strategy is approved. When priorities blur, ownership fragments and progress goes unmeasured, even well-designed plans stall before they reach members. The downstream effects — avoidable utilization, missed engagement…
Jun 25, 2026 11:00 AM - 12:00 PM CDT
Presenters:
- Deb Vona
- Deborah Stewart, MD
- Katherine Musler
- Vimbai Mudimu